The 7-coordinate complex [Fe(qpy)(MeCN)2](ClO4)2 (1, qpy = 2,2':6',2″:6″,2''':6''',2''''-quinquepyridine) is a highly active nonheme iron catalyst for intra- and intermolecular amination of C(sp(3))-H bonds. This complex effectively catalyzes the amination of limiting amounts of not only benzylic and allylic C(sp(3))-H bonds of hydrocarbons but also the C(sp(3))-H bonds of cyclic alkanes and cycloalkane/linear alkane moieties in sulfamate esters, such as those derived from menthane and steroids cholane and androstane, using PhI═NR or "PhI(OAc)2 + H2NR" [R = Ts (p-toluenesulfonyl), Ns (p-nitrobenzenesulfonyl)] as nitrogen source, with the amination products isolated in up to 93% yield. Iron imide/nitrene intermediates [Fe(qpy)(NR)(X)](n+) (CX, X = NR, solvent, or anion) are proposed in these amination reactions on the basis of experimental studies including ESI-MS analysis, crossover experiments, Hammett plots, and correlation with C-H bond dissociation energies and with support by DFT calculations. Species consistent with the formulations of [Fe(qpy)(NTs)2](2+) (CNTs) and [Fe(qpy)(NTs)](2+) (C) were detected by high-resolution ESI-MS analysis of the reaction mixture of 1 with PhI═NTs (4 equiv). DFT calculations revealed that the reaction barriers for H-atom abstraction of cyclohexane by the ground state of 7-coordinate CNTs and ground state of C are 15.3 and 14.2 kcal/mol, respectively, in line with the observed high activity of 1 in catalyzing the C-H amination of alkanes under mild conditions.

The hippocampus, including the dorsal dentate gyrus (dDG), and cortex engage in bidirectional communication. We propose that low-frequency activity in hippocampal-cortical pathways contributes to brain-wide resting-state connectivity to integrate sensory information. Using optogenetic stimulation and brain-wide fMRI and resting-state fMRI (rsfMRI), we determined the large-scale effects of spatiotemporal-specific downstream propagation of hippocampal activity. Low-frequency (1 Hz), but not high-frequency (40 Hz), stimulation of dDG excitatory neurons evoked robust cortical and subcortical brain-wide fMRI responses. More importantly, it enhanced interhemispheric rsfMRI connectivity in various cortices and hippocampus. Subsequent local field potential recordings revealed an increase in slow oscillations in dorsal hippocampus and visual cortex, interhemispheric visual cortical connectivity, and hippocampal-cortical connectivity. Meanwhile, pharmacological inactivation of dDG neurons decreased interhemispheric rsfMRI connectivity. Functionally, visually evoked fMRI responses in visual regions also increased during and after low-frequency dDG stimulation. Together, our results indicate that low-frequency activity robustly propagates in the dorsal hippocampal-cortical pathway, drives interhemispheric cortical rsfMRI connectivity, and mediates visual processing.hippocampus | resting-state functional connectivity | optogenetic | fMRI | low frequency T he hippocampus (HP) plays a prominent role in central nervous system functions, particularly in episodic memory (1, 2) and spatial navigation (3, 4). The HP, including the dentate gyrus (DG), can evoke large-scale influences on cortical activity, because the HP receives convergent information from sensory and limbic cortices before sending reciprocal divergent projections to create a highly interactive corticohippocampal-cortical network. The HP, including DG, CA3, and CA1, and neocortex, are connected via the entorhinal cortex (EC) (5, 6), such that the dorsolateral-to-ventromedial projection that originates in the EC corresponds to a dorsoventral axis of termination in the HP (5). This anatomical topography suggests that a functional gradient could exist along the HP dorsoventral axis. Previous studies demonstrated that dorsal HP (dHP) and cortex are functionally integrated during sensory processing and memory consolidation (7-9). Specifically, dHP can integrate multimodal sensory information and process memory operations (7) using excitatory longrange projections (10). This process occurs over multiple brain circuits, but the role of dHP in complex networks, particularly its influence on brain-wide functional connectivity, is not well understood.Resting-state functional MRI (rsfMRI) (11-14) provides an invaluable, noninvasive imaging technique to map long-range, brain-wide functional connectivity networks based on the temporal coherence of infraslow (0.005-0.1 Hz) blood oxygen level dependent (BOLD) activity. The functional relevance of specific brain-wide networks in co...

Nasopharyngeal cancer (NPC) is an Epstein-Barr virus (EBV)-associated head and neck cancer prevalent in Asia. Although with reasons not fully understood, the intrinsic invasiveness of NPC is believed to be EBV-linked. Recently, EBV was found to induce STAT3 activation. Constitutive STAT3 activation correlated with advanced clinical staging in NPC. We hypothesized that STAT3 activation by EBV directly contributes to the intrinsic invasiveness of NPC cells. Phospho-STAT3-Tyr705 was detected in high percentage of NPC tumors (7/10 cases). Using a paired NPC cell line model, HONE-1 and the EBV-infected counterpart, HONE-1-EBV, we found that HONE-1-EBV expressed a higher level of phospho-STAT3-Tyr705 and was 11-fold more invasive than HONE-1. In HONE-1-EBV, STAT3 siRNA targeting inhibited both spontaneous and serum-induced invasion, as well as cell growth. Conversely, activation of STAT3 (by expressing an activated STAT3 mutant, namely STAT3C) in the parental HONE-1, mimicking EBV-induced STAT3 activation, significantly enhanced its invasiveness and proliferation, which was accompanied by increased expression of markers of mesenchymal status, proliferation and anti-apoptosis. Our results demonstrated that EBVinduced STAT3 activation is responsible for NPC cell proliferation and invasion. This was further confirmed by a small molecule inhibitor of JAK/STAT3, JSI-124. JSI-124 inhibited STAT3 activation in HONE-1-EBV, with subsequent growth inhibition, induction of PARP cleavage, abrogation of anchorage-independent growth and invasion. We found that EBV-independent activation of STAT3 by a growth factor, EGF, also contributed to NPC invasion. In conclusion, EBV-induced STAT3 activation directly contributes to the intrinsic invasiveness of NPC cells and STAT3 targeting may be beneficial in treating aggressive NPC. ' 2009 UICC Key words: STAT3; nasopharyngeal cancer (NPC); EBV; invasion Nasopharyngeal cancer (NPC) is a distinct type of head and neck cancer highly prevalent in Southeast Asia with a strong etiological association with the Epstein-Barr virus (EBV), a wellknown group I carcinogen. 1,2 One hundred percent of NPC cases in endemic regions are EBV positive. 3,4 NPC is also characterized by heavy lymphocyte infiltration (with rich supply of cytokines in the tumor microenvironment), high invasive and metastatic tendency. Recurrent NPC patients have high rate of distant metastasis up to 37%. [5][6][7] The underlying mechanism for its high metastatic characteristics is largely unknown. However, EBV is believed to play a major role.Signal Transducer and Activator of Transcription 3 (STAT3) is constitutively activated or overexpressed in a vast number of human cancers, including breast, lung, prostate, brain, leukemia, multiple myeloma, head and neck squamous cell carcinoma and NPC. [8][9][10][11] This pivotal transcription factor is known to be a key regulator for multiple cellular processes, including cell growth, apoptosis, metastasis, epithelial-mesenchymal transition and differentiation. STAT3 has been proposed to...

[Fe(III)(L-N(4)Me(2))Cl(2)](+) (1, L-N(4)Me(2) = N,N'-dimethyl-2,11-diaza[3.3](2,6)pyridinophane) is an active catalyst for cis-dihydroxylation of various types of alkenes with oxone at room temperature using limiting amounts of alkene substrates. In the presence of 0.7 or 3.5 mol % of 1, reactions of electron-rich alkenes, including cyclooctene, styrenes, and linear alkenes, with oxone (2 equiv) for 5 min resulted in up to >99% substrate conversion and afforded cis-diol products in up to 67% yield, with cis-diol/epoxide molar ratio of up to 16.8:1. For electron-deficient alkenes including α,β-unsaturated esters and α,β-unsaturated ketones, their reactions with oxone (2 equiv) catalyzed by 1 (3.5 mol %) for 5 min afforded cis-diols in up to 99% yield with up to >99% substrate conversion. A large-scale cis-dihydroxylation of methyl cinnamate (9.7 g) with oxone (1 equiv) afforded the cis-diol product (8.4 g) in 84% yield with 85% substrate conversion. After catalysis, the L-N(4)Me(2) ligand released due to demetalation can be reused to react with newly added Fe(ClO(4))(2)·4H(2)O to generate an iron catalyst in situ, which could be used to restart the catalytic alkene cis-dihydroxylation. Mechanistic studies by ESI-MS, isotope labeling studies, and DFT calculations on the 1-catalyzed cis-dihydroxylation of dimethyl fumarate with oxone reveal possible involvement of cis-HO-Fe(V)═O and/or cis-O═Fe(V)═O species in the reaction; the cis-dihydroxylation reactions involving cis-HO-Fe(V)═O and cis-O═Fe(V)═O species both proceed by a concerted but highly asynchronous mechanism, with that involving cis-HO-Fe(V)═O being more favorable due to a smaller activation barrier.

Key risk factors for low BMD-mediated fracture include increased age, low body weight, weight loss, physical inactivity, prolonged corticosteroid use, previous osteoporotic fracture, and androgen deprivation therapy. Non-DXA tests either are too insensitive or have insufficient data to reach conclusions.

"Iron(II) salt + 4,4',4''-trichloro-2,2':6',2''-terpyridine" is an effective catalyst for epoxidation and aziridination of alkenes and intramolecular amidation of sulfamate esters. The epoxidation of allylic-substituted cycloalkenes achieved excellent diastereoselectivities up to 90%. ESI-MS results supported the formation of iron-oxo and -imido intermediates. Derivitization of Cl 3terpy to O-PEG-OCH 3-Cl 2terpy renders the terpyridine unit to be recyclable, and the "iron(II) salt + 4,4''-dichloro-4'- O-PEG-OCH 3-2,2':6',2''-terpyridine" protocol can be reused without a significant loss of catalytic activity in the alkene epoxidation.

No abstract

The success of the clinical uses of cisplatin, cis-[Pt(II)(NH(3))(2)Cl(2)], has stimulated considerable interest in using other metal complexes as new therapeutic agents. This perspective describes our recent work on several classes of gold(III), platinum(II), ruthenium(II, III, IV), iron(II) and vanadium(IV) complexes for anti-cancer and anti-HIV treatments.